Bellerophon Therapeutics, Inc. (BLPH) Social Stream



Bellerophon Therapeutics, Inc. (BLPH): $0.06

0.00 (-1.56%)

POWR Rating

Component Grades

Momentum

C

Stability

F

Sentiment

Quality

C

Add BLPH to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#48 of 393

in industry

BELLEROPHON THERAPEUTICS INC (BLPH) Price Targets From Analysts

Use the tables below to see what analysts covering BELLEROPHON THERAPEUTICS INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-08-09 1 $30 $19 $25 $0.102 24409.8%
2021-11-16 2 $30 $19 $25 $0.102 24409.8%
2022-04-01 2 $30 $26 $28 $0.102 27350.98%
2023-05-15 2 $30 $19 $24.5 $0.102 23919.61%
2023-05-17 3 $30 $19 $22.666 $0.102 22121.57%
2023-06-06 1 $2 $2 $2 $0.102 1860.78%

Price Target Last Issued June 6, 2023

The Trend in the Analyst Price Target


Over the past 19 months, BLPH's average price target has gone down $26.

Over the past 29 weeks, BLPH's average upside potential has been 731.44%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-11-14 2 30 19 24.5 1.12 2087.5%
2023-03-07 2 30 19 24.5 5.00 390%
2023-05-15 2 30 19 24.5 8.71 181.29%
2023-06-06 2 2 2 2.0 0.90 122.22%
2023-06-06 2 19 2 10.5 0.90 1066.67%

BLPH Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.67 2 0 1 0 0 3

The Trend in the Broker Recommendations


BLPH's average broker recommendation rating worsened by 1 over the prior 43 weeks.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for BLPH as an investment opportunity.

  • To contextualize these metrics, consider that out of all US stocks, BELLEROPHON THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is higher than 896.23% of them.
  • In the context of all US stocks, BELLEROPHON THERAPEUTICS INC's number of analysts covering the stock is higher than 35.38% of them.
  • In the context of stocks in the micro market cap category, BELLEROPHON THERAPEUTICS INC's average analyst price target is greater than 573.43% of them.
  • BLPH has a lower variance in analysts' estimates than -147.05% of Pharmaceutical Products stocks.

Stocks similar to BELLEROPHON THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are DARE, AGRX, and AKTX.

Make investment decisions regarding BLPH using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!